1
|
Nosrati M, Nikbakht-Jam I, Eslami S, Khademi MM, Foroutan-Tanha M, Hadizadeh F, Sahebkar AH, Tavallaie S, Taherzadeh Z, Ghayour-Mobarhan M, Ferns GA. Effect of Crocin on Antibody Titers to Heat-Shock Protein 27 in Subjects with Metabolic Syndrome. ACTA ACUST UNITED AC 2018; 12:113-121. [DOI: 10.2174/1574884712666170509162523] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/23/2017] [Revised: 04/26/2017] [Accepted: 04/29/2017] [Indexed: 11/22/2022]
Affiliation(s)
- Mina Nosrati
- Biochemistry and Nutrition Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Irandokht Nikbakht-Jam
- Biochemistry and Nutrition Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Saeid Eslami
- Pharmaceutical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Mohammad M. Khademi
- Student Research Committee, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Mojtaba Foroutan-Tanha
- Student Research Committee, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Farzin Hadizadeh
- Biotechnology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Amir H. Sahebkar
- Biotechnology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Shima Tavallaie
- Biochemistry and Nutrition Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Zhila Taherzadeh
- Targeted Drug Delivery Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
| | | | - Gordon A.A. Ferns
- Brighton & Sussex Medical School, Division of Medical Education, Mayfield House, University of Brighton, Sussex, BN1 9PH, United Kingdom
| |
Collapse
|
2
|
Jam IN, Sahebkar AH, Eslami S, Mokhber N, Nosrati M, Khademi M, Foroutan-Tanha M, Ghayour-Mobarhan M, Hadizadeh F, Ferns G, Abbasi M. The effects of crocin on the symptoms of depression in subjects with metabolic syndrome. ADV CLIN EXP MED 2017; 26:925-930. [PMID: 29068592 DOI: 10.17219/acem/62891] [Citation(s) in RCA: 35] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Abstract
BACKGROUND Studies have suggested that metabolic syndrome (MetS) is associated with increased depressive symptoms, and reducing depression in subjects with MetS is important. Crocin, an active component of saffron, has useful properties for subjects with MetS, including antidepressant properties. OBJECTIVES The aim of the study was to assess the effect of a preparation of crocin on the symptoms of depression in subjects with MetS, and the relationship between changes in those symptoms and the serum pro-oxidant/anti-oxidant balance (PAB). MATERIAL AND METHODS This sub-study was carried out on 34 subjects with MetS from the authors' previous randomized double-blind controlled clinical trial (RCT), all of whom met the inclusion criteria for this study. The subjects were randomly assigned to treatment and placebo groups (n = 17 in each group) and received each 30 mg of crocin (2 tablets of 15 mg) or placebo for 8 weeks. Depressive symptoms were assessed using the Beck Depression Inventory (BDI). The BDI questionnaire was completed for each subject at the baseline and at the end of the 8th week of treatment. Blood samples were taken from the subjects before and after the intervention period. Statistical analyses were performed using the SPSS for Windows, v. 16 (SPSS Inc., Chicago, USA). RESULTS Out of the 34 participants enrolled, 33 completed the trial. The degree of depression decreased significantly in the crocin group (p = 0.005), but not in the placebo group (p > 0.05), and the difference between the 2 groups was statistically significant (p = 0.013). No significant relationship was observed between changes in depression symptoms and changes in the serum PAB (p > 0.05). CONCLUSIONS This study demonstrates that at a dose of 30 mg per day for 8 weeks, crocin reduced the symptoms of depression in subjects with MetS compared to the control group, and this effect was independent of its effect on the serum PAB.
Collapse
Affiliation(s)
- Irandokht Nikbakht Jam
- Metabolic Research Center, School of Medicine, Mashhad University of Medical Sciences, Iran
| | - Amir Hossein Sahebkar
- Biotechnology Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Iran
| | - Saeid Eslami
- Pharmaceutical Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Iran
| | - Naghmeh Mokhber
- Psychiatry and Behavioral Sciences Research Center, School of Medicine, Mashhad University of Medical Sciences, Iran
| | - Mina Nosrati
- Metabolic Research Center, School of Medicine, Mashhad University of Medical Sciences, Iran
| | - Mohammad Khademi
- Pharmaceutical Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Iran
| | - Mojtaba Foroutan-Tanha
- Pharmaceutical Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Iran
| | - Majid Ghayour-Mobarhan
- Metabolic Research Center, School of Medicine, Mashhad University of Medical Sciences, Iran
| | - Farzin Hadizadeh
- Biotechnology Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Iran
| | - Gordon Ferns
- Brighton & Sussex Medical School, Division of Medical Education, Mayfield House, University of Brighton, Staffordshire, UK
| | - Masoumeh Abbasi
- Qaem Hospital Cardiology Department, School of Medicine, Mashhad University of Medical Sciences, Iran
| |
Collapse
|
3
|
Javandoost A, Afshari A, Nikbakht-Jam I, Khademi M, Eslami S, Nosrati M, Foroutan-Tanha M, Sahebkar A, Tavalaie S, Ghayour-Mobarhan M, Ferns G, Hadizadeh F, Tabassi A, Mohajeri A. Effect of crocin, a carotenoid from saffron, on plasma cholesteryl ester transfer protein and lipid profile in subjects with metabolic syndrome: A double blind randomized clinical trial. ARYA Atheroscler 2017; 13:245-252. [PMID: 29371871 PMCID: PMC5774797] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
BACKGROUND Metabolic syndrome is defined by insulin resistance and a clustering of other cardiovascular risk factors. Crocin is a carotenoid derived from the stigmas of the saffron flower and had previously been shown to affect lipid profile. However, the mechanism for this function is not well understood. The present trial aimed to investigate the possible effect of crocin on plasma levels of cholesteryl ester transfer protein and lipid profile in individuals with metabolic syndrome. METHODS This was a randomized, double-blind, placebo-controlled, clinical trial consisting of an 8-week treatment with crocin, or placebo tablets between April and June 2014, in the Nutrition Clinic of Ghaem Teaching Hospital, Mashhad, Iran. Participants were randomly assigned to take a 30 mg/day crocin (n = 22) in the intervention group or placebo (n = 22) in the control group. Anthropometric, hematological and biochemical parameters were measured and recorded during pre and post-treatment periods. RESULTS Whilst plasma cholesteryl ester transfer protein was increased in the group taking the crocin tablet by 27.81% during the trial period (P = 0.013), the difference between the crocin and placebo groups was not significant (P = 0.116). Moreover, the percent changes in cholesterol (P = 0.702), triglyceride (P = 0.080), low-density lipoprotein (LDL) (P = 0.986), high-density lipoprotein (HDL) (P = 0.687) and fasting blood glucose (P = 0.614) did not differ significantly between intervention and control groups. CONCLUSION Although crocin supplements increased the serum cholesteryl ester transfer protein in patients with metabolic syndrome, this change was not significant between treatment and placebo groups.
Collapse
Affiliation(s)
- Ali Javandoost
- Metabolic Syndrome Research Center AND School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Asma Afshari
- Assistant Professor, Department of Nutrition, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Irandokht Nikbakht-Jam
- Metabolic Syndrome Research Center AND School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Mohammad Khademi
- PhD Candidate, Student Research Committee, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Saied Eslami
- Professor, Pharmaceutical Research Center AND School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Mina Nosrati
- Metabolic Syndrome Research Center AND School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Mojtaba Foroutan-Tanha
- Metabolic Syndrome Research Center AND Cardiovascular Research Center AND School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Amirhossein Sahebkar
- Associate Professor, Department of Sciences and Technologies, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Shima Tavalaie
- Metabolic Syndrome Research Center AND School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Majid Ghayour-Mobarhan
- Professor, Cardiovascular Research Center AND Metabolic Syndrome Research Center AND School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran,Correspondence to: Majid Ghayour-Mobarhan,
| | - Gordon Ferns
- School of Brighton and Sussex Medical, Division of Medical Education, Mayfield House, University of Brighton, Brighton, UK
| | - Farzin Hadizadeh
- Professor, Biotechnology Research Center AND School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Abolghasem Tabassi
- Pharmacological Research Center of Medicinal Plants AND School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Ahmad Mohajeri
- Associate Professor, Pharmacological Research Center of Medicinal Plants, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
| |
Collapse
|